Overview

Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.
Phase:
Phase 4
Details
Lead Sponsor:
Henry Ford Health System
Treatments:
Gentamicins
Minocycline